Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, October 30, 2019
Pear Therapeutics has entered into an agreement with Ironwood Pharmaceuticals to evaluate PDTs for the treatment of selected indications within the GI space.
read more
Wednesday, September 09, 2020
Intravacc has been awarded a contract with base and options that may total US$9.4 million from the NIAID for the development of a prophylactic vaccine against enterovirus D68.
read more
Rentschler Biotechnologie GmbH, a CDMO for biopharmaceuticals, and Rentschler Fill Solutions GmbH, an independent specialist for aseptic fill and finish services, have announced a strategic partnership to provide new state-of-the-art fill and finish ...
read more
Wednesday, August 23, 2017
SillaJen has entered into a CRADA with the National Cancer Institute for the development of a combination therapy for colorectal cancer.
read more
Wednesday, December 11, 2013
Marken announced today that their Singapore biological kit-building facility has now been certified to International Standards Organization (ISO) 13485 standards for the storage and distribution of medical devices.
read more
Friday, February 07, 2014
Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio),
a biotechnology company developing DCVax® personalized immune therapies for solid tumor
cancers, announced today that it has entered into a set of agreements for large-scale expansion of
the ...
read more
Monday, December 16, 2019
AGC Biologics is expanding its CDMO services with plasmid DNA (pDNA) offerings from its Heidelberg site in Germany.
read more
Sinclair Research will officially open its 20,000-square-foot laboratory expansion later this spring.
read more
Wednesday, September 08, 2021
Valneva SE, a specialty vaccine company, announced that the U.S. Department of Defense (DoD) has exercised the first option of the contract signed in September 20201 to purchase further supply of its Japanese encephalitis (JE) vaccine IXIARO®.
read more
Wednesday, April 12, 2017
Recipharm AB has announced the appointment of Henrik Stenqvist as Recipharm’s new Executive Vice President and Chief Financial Officer, effective on April 24, 2017. He will be based at the company’s headquarters in Stockholm, Sweden and reports to ...
read more
Iovance Biotherapeutics has selected Avid to provide process development, pilot-batch manufacturing and CGMP manufacturing services to support development of IOV-3001.
read more
Thursday, January 21, 2021
Quanticate has named Lee Patterson as the company's Chief Operating Officer (COO).
read more
Sterling Pharma Solutions, has announced that its customer, ADC Therapeutics SA, has received FDA approval for the antibody drug conjugate ZYNLONTATM that its Deeside facility contributed to developing.
read more
Tuesday, February 25, 2020
Levadura Biotechnology has received the ISR for Levadura’s first Patent Cooperation Treaty patent application.
read more
Monday, November 17, 2014
Almac Group today announced that it has launched a CLIA validated next generation sequencing test for P53 mutations. The P53 test can be run on formalin fixed paraffin embedded (FFPE) samples enabling patient stratification for early phase trial ...
read more